Amylin Pharmaceuticals announced yesterday that they are cutting their work force by 25 percent following unexpectedly slumping sales for their once promising diabetes drug Byetta, which has recently been associated with 6 deaths caused by severe cases of pancreatitis. Continued
All Posts Tagged With: "Pancreatitis"
FDA Requires Additional Byetta Safety Data Before Considering Long-Acting Version
The FDA has rejected data submitted by Amylin Pharmaceuticals for a longer-acting Byetta, which will likely delay the new version of their diabetes drug. This is another blow to Amylin, which has seen their stock price plummet this year after Byetta was linked to fatal pancreatitis cases in August. Continued
Byetta Pen Pancreatitis Concerns Cause Amylin Stock to Fall
Over the eight weeks since concerns first emerged about a potential link between the Byetta pen and pancreatitis, the stock price for the drug’s maker, Amylin Pharmaceuticals, has fallen dramatically. Continued
Seroquel Lawsuit
The use of the antipsychotic medication Seroquel has been linked to an increased risk of diabetes, pancreatitis and death. Thousands of Seroquel lawsuits have been filed throughout the United States by individuals who suffered severe and life threatening injuries. Continued
Byetta Linked to Four More Pancreatitis Deaths
In a conference call late Monday, Eli Lilly & Co. and Amylin Pharmaceuticals, Inc. indicated that they have notified the FDA about four more deaths from pancreatitis among users of their diabetes drug Byetta. These four cases are in addition to two other Byetta pancreatitis deaths the FDA referenced in a notice to healthcare providers issued last week. Continued
Byetta Lawsuit Filed For Pancreatitis
A diabetic patient who developed pancreatitis as a side effect of Byetta has filed a lawsuit in a California state court. This is reportedly the first Byetta lawsuit to be filed in the United States involving pancreatitis. Continued
FDA Warns of Additional Byetta Pancreatitis Reports
On August 18, 2008, the FDA issued an alert to healthcare providers about six additional cases of necrotizing or hemorrhagic pancreatitis among users of Byetta, two of which have resulted in death. The warning follows a prior alert issued by the FDA in October 2007, involving at least 30 other cases that suggested an association between the diabetes drug Byetta and pancreatitis. Continued
Byetta Lawsuits
The use of the diabetes drug Byetta has been linked to the development of serious and potentially fatal pancreatitis. The FDA issued alerts in October 2007 and August 2008 warning doctors about the possible link between side effects of Byetta and pancreatitis. Continued
